India’s pharmaceutical industry is at an inflection point and in this episode, two of its young influential leaders break down where it’s headed next. In this episode of Corner Office Conversation host Vikas Dandekar talks to Nandini Piramal, Chairperson of Piramal Pharma, and Arjun Juneja, COO of Mankind Pharma for an unfiltered conversation on legacy, reinvention, and the race toward innovation. From Piramal’s bold portfolio pivots and quality-first culture to Mankind’s rise from a domestic challenger to a top-three giant, the episode explores how two very different companies are preparing for the coming decade. The leaders discuss drug innovation, India’s obesity-treatment boom, partnerships, global regulatory scrutiny, and why 2047 will be a defining milestone for Indian pharma.
Tune in:

You can follow Vikas Dandekar on his social media: X and Linkedin and read her Newspaper Articles.

Listen to Corner Office Conversation: Corner Office Conversation with Knight Frank’s William Beardmore-Gray and Shishir Baijal, Corner Office Conversation with Sridhar Vembu, CEO, of Zoho Corporation, Corner Office Conversation with Gunjan Soni, Country Managing Director, Youtube India, Corner Office Conversation with Elizabeth Reid, Head of Search, Google and much more.

See omnystudio.com/listener for privacy information.

Corner office Conversation with Nandini Piramal of Piramal Pharma, and Arjun Juneja of Mankind Pharma

The Morning Brief